The life cycle of a drug begins with drug discovery and development, ... i.e., inter-organizational deals that had a direct influence on the development of the drug.

Researchers of all levels can rely on CytoReason’s proprietary data and innovative technology to make data-driven decisions across the drug development life cycle.

WASHINGTON (7News) — As Artificial Intelligence (AI) becomes more popular in everyday life, drug research and development companies are incorporating it into their process. Dotmatics, an early ...

The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological ...

Regulatory guidance relating to analytical procedures is in the process of changing to a lifecycle approach to ensure that procedures are suitable for intended use across all phases of the drug ...

However, MIDD has untapped potential to support the whole drug development life cycle. Its value can extend beyond traditional PK/PD approaches by incorporating epidemiological and health-economic ...

Nearly 50% of life sciences professionals are eager to invest further in automation for process efficiency and cost savings, the report finds. MIAMI, Dec. 21, 2022 /PRNewswire/ -- ArisGlobal, the ...

Moderna’s objective is to integrate AI into all aspects of the drug development life cycle. Moderna has launched the Moderna AI Academy to accelerate training on AI at all levels of the ...

Rejuvenate Biomed to accelerate its drug development pipeline of assets for age-related diseases using jointly developed tools. DIEPENBEEK, Belgium and CARY, N.C., Aug. 1, 2024 /PRNewswire ...

FDA: The FDA's Center for Drug Evaluation and Research (CDER) has seen an increase in the number of drug and biological product applications using AI components for drug development, with over 500 ...